Brief Information of the Cell Line and Protein
Cell Line ID: CL000043 , U2OS
Synonyms
U-2 OS
U-2OS
U-2-OS
U2-OS
U20-S
U20S
2T
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0042
Protein ID: PT06441 , Scavenger receptor class B member 1
Gene Name SCARB1
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q8WTV0
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000043  Protein ID: PT06441
 
Compound ID Compound Name Compound Formula
CP0534618
N-[3-[3-[bis(2-hydroxyethyl)amino]propylsulfonylamino]-5-tert-butyl-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide
   Show/Hide
C36H50N4O9S
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0459610
2-[4-[2-[(2-aminoacetyl)amino]ethoxy]naphthalen-1-yl]-N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-oxoacetamide
   Show/Hide
C28H34N4O7S
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0459611
N-[5-tert-butyl-2-methoxy-3-(propylsulfonylamino)phenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide
   Show/Hide
C32H41N3O7S
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0474108
N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(4-morpholin-4-ylbutoxy)naphthalen-1-yl]-2-oxoacetamide
   Show/Hide
C32H41N3O7S
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0474110
N-[5-tert-butyl-3-[3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propylsulfonylamino]-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide
   Show/Hide
C36H50N4O10S
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0511189
2-[4-[2-[bis(2-hydroxyethyl)amino]ethoxy]naphthalen-1-yl]-N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-oxoacetamide
   Show/Hide
C30H39N3O8S
 1
1
IC50 = 79.43 nM
   TI
   LI
   LO
   TS
CP0278504
N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide
   Show/Hide
C30H37N3O7S
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0474109
3-[[5-tert-butyl-2-methoxy-3-[[2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetyl]amino]phenyl]sulfamoyl]propyl-triethylazanium;2,2,2-trifluoroacetate
   Show/Hide
C40H55F3N4O9S
 1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
CP0572667
N-[3-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethylsulfonylamino)-5-tert-butyl-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide;chloride
   Show/Hide
C36H48ClN5O7S
 1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
CP0401803
2-[[5-tert-butyl-2-methoxy-3-[[2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetyl]amino]phenyl]sulfamoyl]acetic acid
   Show/Hide
C31H37N3O9S
 1
1
IC50 = 199.53 nM
   TI
   LI
   LO
   TS
CP0511188
2-[4-[2-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyanilino]-2-oxoacetyl]naphthalen-1-yl]oxyethyl-trimethylazanium;2,2,2-trifluoroacetate
   Show/Hide
C31H38F3N3O8S
 1
1
IC50 = 501.19 nM
   TI
   LI
   LO
   TS
CP0474107
3-[2-[4-[2-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyanilino]-2-oxoacetyl]naphthalen-1-yl]oxyethylamino]-3-oxopropanoic acid
   Show/Hide
C29H33N3O9S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0534619
1-[2-[4-[2-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyanilino]-2-oxoacetyl]naphthalen-1-yl]oxyethyl]piperidine-4-carboxylic acid
   Show/Hide
C32H39N3O8S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0554834
N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-[2-(4-methylmorpholin-4-ium-4-yl)ethoxy]naphthalen-1-yl]-2-oxoacetamide;2,2,2-trifluoroacetate
   Show/Hide
C33H40F3N3O9S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0554835
2-[3-[[5-tert-butyl-2-methoxy-3-[[2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetyl]amino]phenyl]sulfamoyl]propyl-(carboxymethyl)amino]acetic acid
   Show/Hide
C36H46N4O11S
 1
1
IC50 = 5011.87 nM
   TI
   LI
   LO
   TS
CP0511190
2-[2-[4-[2-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyanilino]-2-oxoacetyl]naphthalen-1-yl]oxyethyl-(carboxymethyl)amino]acetic acid
   Show/Hide
C30H35N3O10S
 1
1
IC50 > 31622.78 nM
   TI
   LI
   LO
   TS